BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Anugayathri Jawahar, Beverly Gonzalez, Neelam Balasubramanian, William Adams, Ari Goldberg. Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liverEuropean Journal of Gastroenterology & Hepatology 2020; 32(2): 216 doi: 10.1097/MEG.0000000000001502
2
Josep Franch-Nadal, Llorenç Caballeria, Manel Mata-Cases, Didac Mauricio, Carolina Giraldez-García, José Mancera, Albert Goday, Xavier Mundet-Tudurí, Enrique Regidor, Yu Wang. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS studyPLOS ONE 2018; 13(6): e0198327 doi: 10.1371/journal.pone.0198327
3
Marta Iruarrizaga-Lejarreta, Fernando Bril, Mazen Noureddin, Pablo Ortiz, Shelly C. Lu, José M. Mato, Cristina Alonso. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 423 doi: 10.1007/978-3-030-11748-1_16
4
Haruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, Shogo Ohkoshi. Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese PopulationJournal of Clinical and Translational Hepatology 2019; 7(2): 1 doi: 10.14218/JCTH.2018.00048
5
Christina N. Katsagoni, Michael Georgoulis, George V. Papatheodoridis, Elisabeth Fragopoulou, Panagiota Ioannidou, Mariviki Papageorgiou, Alexandra Alexopoulou, Nikolaos Papadopoulos, Melanie Deutsch, Meropi D. Kontogianni. Associations Between Lifestyle Characteristics and the Presence of Nonalcoholic Fatty Liver Disease: A Case–Control StudyMetabolic Syndrome and Related Disorders 2017; 15(2): 72 doi: 10.1089/met.2016.0105
6
Shaham Mumtaz, Nathan Schomaker, Natasha Von Roenn. Pro: Noninvasive Imaging Has Replaced Biopsy as the Gold Standard in the Evaluation of Nonalcoholic Fatty Liver DiseaseClinical Liver Disease 2019; 13(4): 111 doi: 10.1002/cld.750
7
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis BiomarkersDisease Markers 2020; 2020: 1 doi: 10.1155/2020/8822859
8
Zhilu Xu, Xiang Zhang, Jennie Lau, Jun Yu. C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implicationExpert Reviews in Molecular Medicine 2016; 18 doi: 10.1017/erm.2016.16
9
L. A. Strashok, O. V. Buznytska. Experience of using static hepatoscintigraphy to assess the functional state of the liver in adolescents with metabolic syndromeProblems of Uninterrupted Medical Training and Science 2019; 2019(2): 18 doi: 10.31071/promedosvity2019.02.018
10
Na Di, Xinchuan Zhou, Yaxiao Chen, Xiaomiao Zhao, Lin Li, Linlin Jiang, Baoming Luo, Xiaoli Chen, Dongzi Yang. Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?Archives of Endocrinology and Metabolism 2019;  doi: 10.20945/2359-3997000000119
11
Maggie A. Stanislawski, Jessica Shaw, Elizabeth Litkowski, Ethan M. Lange, Wei Perng, Dana Dabelea, Leslie A. Lange. Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children StudyThe Journal of Pediatrics 2020; 220: 146 doi: 10.1016/j.jpeds.2020.01.031
12
O. V. Buznytska. Diagnostic significance of biochemical indicators of liver fibrogenesis in adolescents with obesityThe Ukrainian Biochemical Journal 2019; 91(1): 74 doi: 10.15407/ubj91.01.074
13
Judith Aron-Wisnewsky, Chloé Vigliotti, Julia Witjes, Phuong Le, Adriaan G. Holleboom, Joanne Verheij, Max Nieuwdorp, Karine Clément. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disordersNature Reviews Gastroenterology & Hepatology 2020; 17(5): 279 doi: 10.1038/s41575-020-0269-9
14
D. Macut, K. Tziomalos, I. Božić-Antić, J. Bjekić-Macut, I. Katsikis, E. Papadakis, Z. Andrić, D. Panidis. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndromeHuman Reproduction 2016; 31(6): 1347 doi: 10.1093/humrep/dew076
15
A Lum Han. Association between Non-Alcoholic Fatty Liver Disease and Dietary Habits, Stress, and Health-Related Quality of Life in Korean AdultsNutrients 2020; 12(6): 1555 doi: 10.3390/nu12061555
16
Anugayathri Jawahar, Beverly Gonzalez, Neelam Balasubramanian, William Adams, Ari Goldberg. Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinationsEuropean Journal of Gastroenterology & Hepatology 2017; 29(12): 1389 doi: 10.1097/MEG.0000000000000972
17
Fernando Bril, Kenneth Cusi. Nonalcoholic Fatty Liver DiseaseEndocrinology and Metabolism Clinics of North America 2016; 45(4): 765 doi: 10.1016/j.ecl.2016.06.005
18
Alessandro Ciresi, Valentina Guarnotta, Daniela Campo, Carla Giordano. Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease ControlInternational Journal of Endocrinology 2018; 2018: 1 doi: 10.1155/2018/5421961
19
Qian Li, Manish Dhyani, Joseph R Grajo, Claude Sirlin, Anthony E Samir. Current status of imaging in nonalcoholic fatty liver diseaseWorld Journal of Hepatology 2018; 10(8): 530-542 doi: 10.4254/wjh.v10.i8.530
20
Jae Yeon Lee, Dong Wook Shin, Jeong Won Oh, Won Kim, Sae Kyung Joo, Myung Jae Jeon, Sun Min Kim, Jae Moon Yun, Ki Young Son, Jin Ho Park, Belong Cho, Seung Mi Lee, Silvia C. Sookoian. Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal womenPLOS ONE 2017; 12(8): e0182708 doi: 10.1371/journal.pone.0182708
21
Alba Otoni, Carlos Mauricio de Figueiredo Antunes, Fernanda Ferreira Tavares, Débora Heloísa Quadros Araújo, Thiago de Almeida Pereira, Leonardo Campos de Queiroz, Frederico Figueiredo Amâncio, José Roberto Lambertucci. Thrombocytopenia as a marker of liver steatosis in a low-endemic area for schistosomiasis mansoniRevista da Associação Médica Brasileira 2017; 63(6): 532 doi: 10.1590/1806-9282.63.06.532
22
Per Stål. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significanceWorld Journal of Gastroenterology 2015; 21(39): 11077-11087 doi: 10.3748/wjg.v21.i39.11077
23
Lawrence Serfaty. Management of patients with non-alcoholic steatohepatitis (NASH) in real lifeLiver International 2018; 38: 52 doi: 10.1111/liv.13637
24
İsa Çam, Ural Koc, Samet Genez, Abdullah Güneş. Computed Tomography Measurements of Hepatic Steatosis in Cholelitihiasis and Cholecystectomy Cases Using Unenhanced ImagesJournal of Medical Imaging and Radiation Sciences 2020; 51(1): 137 doi: 10.1016/j.jmir.2019.12.003
25
Maria Pokorska-Śpiewak, Barbara Kowalik-Mikołajewska, Małgorzata Aniszewska, Magdalena Pluta, Magdalena Marczyńska. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis CBMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2462-1
26
Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, Francesca Urbano, Agnese Filippello, Marco Ragusa, Maria T. Di Martino, Francesca Scionti, Stefania Grimaudo, Rosaria M. Pipitone, Graziella Privitera, Antonino Di Pino, Roberto Scicali, Luca Valenti, Paola Dongiovanni, Anna Fracanzani, Agata M. Rabuazzo, Antonio Craxì, Michele Purrello, Francesco Purrello, Salvatore Piro. Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severityLiver International 2019; 39(9): 1742 doi: 10.1111/liv.14167
27
Kenneth Cusi. Diabetes and ExerciseContemporary Diabetes 2018; : 47 doi: 10.1007/978-3-319-61013-9_4
28
Chunfang Xu, Zhenguo Qiao, Yongda Lu, Deqing Zhang, Zhenyu Jia, Xiaohui Zhuang, Yuqi Shi, Ting Xu, Lihua Xing, Jiaqing Shen, Zoltán Rakonczay. Influence of Fatty Liver on the Severity and Clinical Outcome in Acute PancreatitisPLOS ONE 2015; 10(11): e0142278 doi: 10.1371/journal.pone.0142278
29
Jamak Modaresi Esfeh, Kianoush Ansari-Gilani. Steatosis and hepatitis CGastroenterology Report 2015; : gov040 doi: 10.1093/gastro/gov040
30
Tae-Hoon Kim, Hong Young Jun, Ki-Jong Kim, Young Hwan Lee, Myeung Su Lee, Keum Ha Choi, Ki Jung Yun, Yong Yeon Jeong, Chung Hwan Jun, Eun Young Cho, Kwon-Ha Yoon. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo TimeJournal of Magnetic Resonance Imaging 2017; 46(5): 1298 doi: 10.1002/jmri.25673
31
Djuro Macut, Ivana Božić-Antić, Jelica Bjekić-Macut, Konstantinos Tziomalos. MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver diseaseEuropean Journal of Endocrinology 2017; 177(3): R145 doi: 10.1530/EJE-16-1063
32
Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Bong-Yun Cha, Min-Hee Kim. Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32245-0
33
Parambir S. Dulai, Claude B. Sirlin, Rohit Loomba. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practiceJournal of Hepatology 2016; 65(5): 1006 doi: 10.1016/j.jhep.2016.06.005
34
Sheng Wang, Jian-Qing Wang, Xiong-Wen Lv. Exosomal miRNAs as biomarkers in the diagnosis of liver diseaseBiomarkers in Medicine 2017; 11(6): 491 doi: 10.2217/bmm-2017-0011